Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.

Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.

Background <br/> Single gene tests to predict whether cancers respond to specific targeted therapies are performed increasingly often. Advances in sequencing technology, collectively referred to as next generation sequencing (NGS), mean the entire cancer genome or parts of it can now be sequen...

Full description

Bibliographic Details
Main Authors: Hamblin, A, Wordsworth, S, Fermont, J, Page, S, Kaur, K, Camps, C, Kaisaki, P, Gupta, A, Talbot, D, Middleton, M, Henderson, S, Cutts, A, Vavoulis, D, Housby, N, Tomlinson, I, Taylor, J, Schuh, A
Format: Journal article
Language:English
Published: Public Library of Science 2017

Similar Items

Similar Items